Anti-adhesion antibodies

Springer, 1994, Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm, Cell, 76, 301, 10.1016/0092-8674(94)90337-9 Butcher, 1996, Lymphocyte homing and homeostasis, Science, 272, 60, 10.1126/science.272.5258.60 Belin, 1995, α4 integrins mediate lymphocyte attachment and rolling under physiologic flow, Cell, 80, 413, 10.1016/0092-8674(95)90491-3 Geijtenbeek, 2000, DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking, Nature Immunol, 1, 353, 10.1038/79815 CeGrendele, 1996, CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothelial cell primary adhesion pathway, J Exp Med, 183, 1119, 10.1084/jem.183.3.1119 Tietz, 1998, CD4+ T cells migrate into inflamed skin only if they express ligands for E- and P-selectin, J Immunol, 161, 963, 10.4049/jimmunol.161.2.963 Nelson, 2001, Chemokines, chemokine receptors and allograft rejection, Immunity, 14, 377, 10.1016/S1074-7613(01)00118-2 Coito, 2000, Extracellular matrix proteins in organ transplantation, Transplantation, 69, 2465, 10.1097/00007890-200006270-00001 Rao, 2000, Potent costimulation of effector T lymphocytes by human collagen type I, J Immunol, 165, 4935, 10.4049/jimmunol.165.9.4935 Gunzer, 2000, Antigen presentation in extracellular matrix: Interactions of T cells with dendritic cells are dynamic, short lived and sequential, Immunity, 13, 323, 10.1016/S1074-7613(00)00032-7 Grakoui, 1999, The immunological synapse: a molecular machine controlling T cell activation, Science, 285, 221, 10.1126/science.285.5425.221 Monks, 1998, Three-dimensional segregation of supramolecular activation clusters in T cells, Nature, 395, 82, 10.1038/25764 Arnaout, 1990, Structure and function of the leukocyte adhesion molecules CD11/CD18, Blood, 75, 1037, 10.1182/blood.V75.5.1037.1037 Benjamin, 1988, Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination, Eur J Immunol, 18, 1079, 10.1002/eji.1830180717 Nakakura, 1993, Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion, Transplantation, 55, 412 Morikawa, 2001, Prolonged inhibition of obliterative airway disease in murine tracheal allografts by brief treatment with anti-leukocyte function-associated antigen-1 (CD11a) monoclonal antibody, Transplantation, 71, 1616, 10.1097/00007890-200106150-00022 Werther, 1996, Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1, J Immunol, 157, 4986, 10.4049/jimmunol.157.11.4986 Bauer, 1999, Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis, J Pharmacokinet Biopharm, 27, 397, 10.1023/A:1020917122093 Gottlieb, 2000, Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis, J Am Acad Dermatol, 42, 428, 10.1016/S0190-9622(00)90214-7 Gottlieb A, Krueger JG, Dedrick R, et al. Psoriasis as a model for T-cell-mediated disease: immunologic and clinical effects of treatment with multiple doses of an anti-CD11a antibody. Arch Dermatol (in press). Papp, 2000, The effective treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody, J Am Acad Dermatol, 45, 665, 10.1067/mjd.2001.117850 Gottlieb, 1995, Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis, Nat Med, 1, 442, 10.1038/nm0595-442 Bos, 1999, The pathogenesis of psoriasis: immunological facts and speculations, Immunol Today, 20, 40, 10.1016/S0167-5699(98)01381-4 Fredriksson, 1978, Severe psoriasis-oral therapy with a new retinoid, Dermatologica, 157, 238, 10.1159/000250839 Hourmant, 1994, Administration of ant anti-CD11a monoclonal antibody in recipients of kidney transplantation: a pilot study, Transplantation, 58, 377, 10.1097/00007890-199408000-00023 Le Mauff, 1991, Effect of anti-LFA-1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation, Transplant Rev, 174, 1259 Stoppa, 1991, Anti-LFA-1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III–IV acute graft-versus-host disease, Transplant Int, 4, 3 Takazawa, 1996, Synergistic effects of mycophenolate mofetil (MMF, RS-61 443) and anti-LFA-1/ICAM-1 monoclonal antibodies on the prolongation of heart allograft survival in rats, Transplant Proc, 28, 1980 Abramowicz, 1989, Release of tumor necrosis factor, interleukin-2 and gamma-inerferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients, Transplantation, 47, 606, 10.1097/00007890-198904000-00008